Unum Therapeutics Inc. (UMRX) has 6 open-market insider trades by 4 insiders since 2018. The most active filer is Seth Ettenberg, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Liam Ratcliffe | Dir | — | 1 | $3.3M | 2018-04-03 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | — | 1 | $1.4M | 2020-08-18 |
| Bruce Booth | Dir | — | 1 | $1.1M | 2018-04-03 |
| Seth Ettenberg | CSO | — | 3 | $321K | 2019-03-25 |
| FMR LLC | — | — | 0 | — | 2018-04-03 |
| Atlas Venture Associates IX, LLC | 10% Owner | — | 0 | — | 2018-04-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Buy | $1.4M | 2020-08-14 |
| Seth Ettenberg | Chief Scientific Officer | Sell | $47K | 2019-03-25 |
| Seth Ettenberg | Chief Scientific Officer | Sell | $49K | 2019-02-25 |
| Seth Ettenberg | Chief Scientific Officer | Sell | $47K | 2018-12-26 |
| Seth Ettenberg | CSO | Sell | $80K | 2018-11-26 |
| Seth Ettenberg | CSO | Sell | $194K |
Companies that share insiders with UMRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-10-25 |
| Seth Ettenberg | CSO | Sell | $286K | 2018-09-25 |
| Liam Ratcliffe | Director | Buy | $3.3M | 2018-04-03 |
| Bruce Booth | Director | Buy | $1.1M | 2018-04-03 |